Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria.
about
Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney diseaseManagement of mild hypertension. Selecting an antihypertensive regimen.Renoprotective role of ACE inhibitors in diabetic nephropathyDevelopment of a replicated database of DHCP data for evaluation of drug use.Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with Type 1 diabetes mellitus.Failure of evidence-based medicine in the treatment of hypertension in older patients.Blood pressure and cardiac autonomic function in relation to risk factors and treatment perspectives in Type 1 diabetes.The cost of major comorbidity in people with diabetes mellitusACE inhibitor intervention in Type 1 diabetes with low grade microalbuminuria.Comparison of reduction in microalbuminuria by enalapril and hydrochlorothiazide in normotensive patients with insulin dependent diabetes.Renal haemodynamic characteristics in patients with lupus nephritisHome blood pressure monitoring in diabetes.Evidence-based guide to slowing the progression of early renal insufficiency.Effect of captopril on blood pressure and kidney function in normotensive insulin dependent diabetics with nephropathyEffects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study).Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up studyPrimary, secondary and tertiary prevention of non-insulin-dependent diabetesMicroalbuminuria and coronary heart disease in non-diabetics.Risk for renal injury in diabetic hypertensive patients. Pharmacologic approaches.Role of glycaemic control in development of microalbuminuria in patients with insulin dependent diabetes.Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group.Diabetic nephropathy: new directions in management.Lack of association between the angiotensin-converting enzyme gene (I/D) polymorphism and diabetic nephropathy in Tunisian type 2 diabetic patients.Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes?The expanding role of angiotensin converting enzyme inhibitors in the management of hypertension.Angiotensin-converting enzyme inhibitors in diabetic nephropathy.Microalbuminuria: a marker to increased renal and cardiovascular risk in diabetes mellitus.Diabetic nephropathy. What you need to know to preserve kidney function.Hypertension education: an important and neglected part of the diabetes education curriculum?Genetics of angiotensin I-converting enzyme.Microalbuminuria and nephropathy in insulin dependent diabetes mellitus.Angiotensin converting enzyme inhibitors and diabetic nephropathy.Adding a statin to a combination of ACE inhibitor and ARB normalizes proteinuria in experimental diabetes, which translates into full renoprotection.Nephrology, dialysis and transplantation.Prevention of diabetic nephropathy with enalapril.Lisinopril reduces albuminuria during exercise in low grade microalbuminuric type 1 diabetic patients: a double blind randomized study.Predictive value of microalbuminuria in longstanding insulin dependent diabetes.The relative prognosis of nodular and diffuse diabetic nephropathy.Levels of NT-proBNP, markers of low-grade inflammation, and endothelial dysfunction during spironolactone treatment in patients with diabetic kidney disease.Comparison of effects of quinapril and metoprolol on glycaemic control, serum lipids, blood pressure, albuminuria and quality of life in non-insulin-dependent diabetes mellitus patients with hypertension. Swedish Quinapril Group.
P2860
Q24244197-9A057E39-6D91-4898-9597-B6E9A833C53CQ33558825-1C8AE331-28CE-4D95-869C-E89BDE448465Q33614282-9E00A046-009A-43CE-A665-B277D1603CEEQ33873096-B011A79E-962E-4B57-BF7C-9E295F82934FQ33899769-AE762DB0-7616-4C2A-8EA2-56653EE6F0BCQ34088224-B08BCEEA-ABFF-4002-87E2-8D4EBA8E2471Q35065524-EE909BFE-9FF5-4287-911A-6E1A5E74DCAFQ35099421-CEC689A4-FFB9-4439-8770-526913DA8030Q35106214-D91178BF-5D7D-44B6-A451-22F6DDC51A9BQ35186385-6ACFC7FF-9010-4174-80F6-586C8060BD52Q35547805-5DE4A606-43C8-4735-B6FF-877C287F8650Q35628020-A47F088D-539B-471E-8CA1-EA7E007EB733Q35641499-C5EEADA0-7B3D-4623-96A6-47E1B98F5087Q35715471-94765E86-8213-42BD-905A-B51A30F57146Q36456306-2485B7C7-80B7-4E75-A092-DC4072C253FAQ36600164-33FA1665-CAF6-4587-945E-C9E947CC8B59Q36679070-CCE8841C-CE4C-4EE4-B464-EB80DC2EAF79Q36683530-BF913C90-7ABF-4809-8C95-E0E2F11C16EAQ36783078-75A6ACE1-0005-468B-AEC8-87D7D468E20EQ36888842-B2B29B8B-D7E3-48EE-B9F7-75351E4C3AF1Q37365616-7973127E-312A-4656-95CB-5B42848BBD84Q37537759-9233EEDE-D042-4F4C-9944-B7C376149E78Q38879240-A639BA1A-2E56-40AF-B4F3-D26D5391CA1BQ40399759-F43F634E-A897-45CE-8AAE-06EFF6EE12D4Q40468415-89C44695-42BE-4155-9272-4732DFE6699DQ40852223-BD4D911E-C2D3-4D02-9537-B89F05C8F74FQ40884232-051F058E-B4F4-4003-862B-81E40512FA2BQ40890537-7FF030ED-8944-4BA3-8FBA-37CCD1BDA79BQ41473792-AAFEC585-4892-4809-93E1-8B576A073DF9Q41554348-4C3002CB-5CD6-48F7-A299-650492FB63EDQ41776733-86BDBF3C-2DDA-4989-A84F-781AB8B42EF5Q42766659-DA54AB4A-B1A1-4E2F-96B8-924C260A3432Q42933669-E4E249FE-D170-4E3C-B0D6-4C444EC5ADCCQ42973858-89A682C7-38D1-4D83-88B4-0F76652E1365Q43379819-C07E0C58-ABD0-44F6-A01D-89D849FF3FB6Q43605947-2056E513-8A96-4DF1-A28F-381E691F5167Q43717780-20352829-7669-4065-93B1-08A7372CAFF0Q43725915-3D957E5A-6FB5-40E4-9EB4-EAF4453BAE12Q48317107-68AB8B26-4FC7-4987-9464-726EEAA858EEQ51564542-13D65E1F-F7F1-4DBA-8A5E-44DEEC56BB97
P2860
Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Prevention of diabetic nephrop ...... abetics with microalbuminuria.
@ast
Prevention of diabetic nephrop ...... abetics with microalbuminuria.
@en
type
label
Prevention of diabetic nephrop ...... abetics with microalbuminuria.
@ast
Prevention of diabetic nephrop ...... abetics with microalbuminuria.
@en
prefLabel
Prevention of diabetic nephrop ...... abetics with microalbuminuria.
@ast
Prevention of diabetic nephrop ...... abetics with microalbuminuria.
@en
P2093
P2860
P1433
P1476
Prevention of diabetic nephrop ...... abetics with microalbuminuria.
@en
P2093
P2860
P304
P356
10.1136/BMJ.297.6656.1092
P407
P577
1988-10-01T00:00:00Z